[{"address1": "12730 High Bluff Drive", "address2": "Suite 400", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 500 8800", "website": "https://kuraoncology.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. Its lead product candidate includes ziftomenib, a selective investigational inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a selective investigational FTI for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification; strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize its oral menin inhibitor for the treatment of patients with acute myeloid leukemia (AML) and other hematologic malignancies; and a clinical collaboration with Mirati Therapeutics, Inc. to evaluate the combination of KO-2806 and adagrasib, a KRASG12C inhibitor in patients with NSCLC. The company is headquartered in San Diego, California.", "fullTimeEmployees": 192, "companyOfficers": [{"maxAge": 1, "name": "Dr. Troy Edward Wilson J.D., Ph.D.", "age": 55, "title": "Chairman, CEO & President", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1296258, "exercisedValue": 1234936, "unexercisedValue": 15624}, {"maxAge": 1, "name": "Ms. Kathleen  Ford", "age": 77, "title": "Chief Operating Officer", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 868935, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Teresa Brophy Bair Esq., J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 745021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Doyle", "age": 53, "title": "Senior Vice President of Finance & Accounting", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francis J. Burrows Ph.D.", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Greg  Mann", "title": "Senior Vice President of Investor Relations & Corporate Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Roger  Bakale Ph.D.", "title": "Senior Vice President of Manufacturing & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maureen  Clancy M.B.A.", "title": "VP and Global Head of Program Leadership & Project Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mollie  Leoni M.D.", "age": 46, "title": "Chief Medical Officer", "yearBorn": 1978, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian T. Powl M.B.A., M.S.", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.46, "open": 10.48, "dayLow": 10.17, "dayHigh": 10.56, "regularMarketPreviousClose": 10.46, "regularMarketOpen": 10.48, "regularMarketDayLow": 10.17, "regularMarketDayHigh": 10.56, "payoutRatio": 0.0, "beta": 0.21, "forwardPE": -4.495608, "volume": 1449660, "regularMarketVolume": 1449660, "averageVolume": 1885141, "averageVolume10days": 1422760, "averageDailyVolume10Day": 1422760, "bid": 10.19, "ask": 10.26, "bidSize": 4, "askSize": 4, "marketCap": 889319104, "fiftyTwoWeekLow": 5.41, "fiftyTwoWeekHigh": 12.49, "allTimeHigh": 43.0, "allTimeLow": 2.5, "priceToSalesTrailing12Months": 8.548761, "fiftyDayAverage": 10.5241, "twoHundredDayAverage": 7.7048, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 359120032, "profitMargins": -2.0848398, "floatShares": 64213707, "sharesOutstanding": 87017518, "sharesShort": 7990490, "sharesShortPriorMonth": 8675680, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.091800004, "heldPercentInsiders": 0.01969, "heldPercentInstitutions": 0.97543, "shortRatio": 3.83, "shortPercentOfFloat": 0.092, "impliedSharesOutstanding": 87017518, "bookValue": 2.787, "priceToBook": 3.6670256, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -216884000, "trailingEps": -2.48, "forwardEps": -2.27333, "enterpriseToRevenue": 3.452, "enterpriseToEbitda": -1.503, "52WeekChange": 0.048621535, "SandP52WeekChange": 0.13613915, "quoteType": "EQUITY", "currentPrice": 10.22, "targetHighPrice": 76.0, "targetLowPrice": 16.0, "targetMeanPrice": 33.0, "targetMedianPrice": 28.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 549665024, "totalCashPerShare": 6.317, "ebitda": -238984992, "totalDebt": 19466000, "quickRatio": 4.828, "currentRatio": 5.117, "totalRevenue": 104029000, "debtToEquity": 8.026, "revenuePerShare": 1.19, "returnOnAssets": -0.26569998, "returnOnEquity": -0.65099996, "grossProfits": -120284000, "freeCashflow": -104869872, "operatingCashflow": 87800000, "grossMargins": -1.15625, "ebitdaMargins": -2.29729, "operatingMargins": -3.8552802, "financialCurrency": "USD", "symbol": "KURA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -2.29445, "regularMarketPrice": 10.22, "marketState": "CLOSED", "exchange": "NMS", "messageBoardId": "finmb_282774456", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1765583913, "regularMarketTime": 1765573202, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1442410200000, "postMarketChangePercent": 1.7612461, "postMarketPrice": 10.4, "postMarketChange": 0.17999935, "regularMarketChange": -0.24, "regularMarketDayRange": "10.17 - 10.56", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1885141, "fiftyTwoWeekLowChange": 4.8100004, "fiftyTwoWeekLowChangePercent": 0.88909435, "shortName": "Kura Oncology, Inc.", "longName": "Kura Oncology, Inc.", "fiftyTwoWeekRange": "5.41 - 12.49", "fiftyTwoWeekHighChange": -2.2699995, "fiftyTwoWeekHighChangePercent": -0.18174537, "fiftyTwoWeekChangePercent": 4.8621535, "earningsTimestamp": 1762263000, "earningsTimestampStart": 1762263000, "earningsTimestampEnd": 1762263000, "earningsCallTimestampStart": 1762261200, "earningsCallTimestampEnd": 1762261200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.48, "epsForward": -2.27333, "epsCurrentYear": -2.33889, "priceEpsCurrentYear": -4.369594, "fiftyDayAverageChange": -0.30410004, "fiftyDayAverageChangePercent": -0.028895585, "twoHundredDayAverageChange": 2.5152001, "twoHundredDayAverageChangePercent": 0.32644588, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Kura Oncology", "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]